ChemoCentryx EV/EBITDA Ratio 2011-2026 | CCXI

Annual EV/EBITDA Ratio ChemoCentryx

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-0.721	-68.7	-40.7	-15.3	25.5	-7.94	-3.19	-7.25	-6.58	-10	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
25.5	-68.7	-13.5

EV/EBITDA Ratio of other stocks in the Biotechnology industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-0.591	-	2.43 %	$ 254 M	Germany
Celldex Therapeutics CLDX	0.185	$ 34.99	3.35 %	$ 2.32 B	USA
Alterity Therapeutics Limited ATHE	-0.994	$ 4.36	9.92 %	$ 10.5 B	Australia
Adverum Biotechnologies ADVM	-1.32	-	-	$ 86.2 M	USA
Akouos AKUS	-1.13	-	0.23 %	$ 488 M	USA
I-Mab IMAB	595	-	-	$ 866 M	China
AlloVir ALVR	-3.61	-	4.14 %	$ 49.1 M	USA
Citius Pharmaceuticals CTXR	-2.05	$ 0.88	2.99 %	$ 5.92 M	USA
Alexion Pharmaceuticals, Inc. ALXN	10.7	-	-	$ 40.3 B	USA
Genfit SA GNFT	4.22 K	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Akari Therapeutics, Plc AKTX	-249	$ 5.52	7.71 %	$ 372 B	Britain
Aligos Therapeutics ALGS	-2.41	$ 6.66	-13.05 %	$ 65.8 M	USA
Alnylam Pharmaceuticals ALNY	-31.5	$ 309.33	-3.37 %	$ 40.5 B	USA
Allakos ALLK	-1.56	-	-	$ 28.6 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	-3.42	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	0.796	-	-18.52 %	$ 27.3 M	Britain
Forte Biosciences FBRX	0.658	$ 32.91	4.71 %	$ 426 M	USA
Applied Molecular Transport AMTI	-1.19	-	-	$ 10.1 M	USA
Galectin Therapeutics GALT	-1.92	$ 2.47	9.29 %	$ 158 M	USA
Amphastar Pharmaceuticals AMPH	17.3	$ 22.62	3.71 %	$ 1.06 B	USA
Applied Therapeutics APLT	-0.476	-	-	$ 8.42 M	USA
BioNTech SE BNTX	4.1	$ 104.72	2.55 %	$ 27.2 B	Germany
Aptinyx APTX	-1.56	-	-39.0 %	$ 4.57 M	USA
Galapagos NV GLPG	-26.5	$ 29.25	1.35 %	$ 2.69 B	Belgium
Aravive ARAV	-0.158	-	-13.39 %	$ 1.45 M	USA
Институт стволовых клеток человека ISKJ	14	-	-	-	Russia
Grifols, S.A. GRFS	13.7	$ 8.73	1.54 %	$ 6.83 B	Spain
Advaxis ADXS	-82.4	-	-9.65 %	$ 45.9 M	USA
GT Biopharma GTBP	-1.47	$ 0.38	-3.91 %	$ 2.1 M	USA
Can-Fite BioPharma Ltd. CANF	-43.1	$ 3.04	-1.3 %	$ 5 M	Israel
Aeterna Zentaris AEZS	4.4	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-1.85	-	-10.17 %	$ 12.2 K	USA
BioXcel Therapeutics BTAI	-2.43	$ 1.19	10.75 %	$ 14.5 M	USA
Aeglea BioTherapeutics AGLE	-4.27	-	-	$ 1.01 B	USA
Hoth Therapeutics HOTH	0.527	$ 0.72	-3.12 %	$ 9.94 M	USA
Akebia Therapeutics AKBA	-2.4	$ 1.44	6.65 %	$ 370 M	USA
Ayala Pharmaceuticals AYLA	0.785	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	0.546	-	-	$ 26.5 M	USA
Harmony Biosciences Holdings HRMY	23	$ 30.25	2.82 %	$ 1.74 B	USA
Aquestive Therapeutics AQST	-7.26	$ 4.37	2.58 %	$ 467 M	USA
InflaRx N.V. IFRX	-3.65	$ 1.56	29.91 %	$ 152 M	Germany
AstraZeneca PLC AZN	76.5	-	-	$ 96.9 B	Britain
Arcutis Biotherapeutics ARQT	-4.86	$ 24.77	2.4 %	$ 3.15 B	USA
AIkido Pharma AIKI	-45.5	-	1.93 %	$ 17.4 M	USA
Brainstorm Cell Therapeutics BCLI	-5.59	-	-2.5 %	$ 5.88 M	USA
Immutep Limited IMMP	-2.76	$ 0.59	1.79 %	$ 1.08 B	Australia
BioDelivery Sciences International BDSI	8	-	-4.8 %	$ 255 M	USA
Cabaletta Bio CABA	0.778	$ 3.41	-3.12 %	$ 343 M	USA